Simulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and Therapeutics
Summary
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of population pharmacokinetic and pharmacodynamic modeling and simulation services, today announced that its Cognigen division has awarded a grant to the Department of Pharmacology and Therapeutics at Makerere University in Kampala, Uganda, the country’s largest and oldest institution of higher learning, to fund upgraded internet capabilities, ensuring access to Cognigen’s KIWITM platform. Dr. Joel Owen, vice president of Pharmacometric Services, Cognigen Corporation, and Dr. Jackson Mukonzo, Senior Lecturer and Chair of the Department of Pharmacology and Therapeutics, Makerere University College of Health Science, will serve as project leads and will oversee the award and use of KIWI. KIWI provides the functionality to meet the scientist’s need for extensive documentation of the analysis pathway and collateral results, management’s need for summaries of modeling and simulation highlights, and regulatory agencies’ needs for transparency and reproducibility. With this grant, we hope to promote the widespread use of quantitative modeling and simulation-based approaches to optimize treatment options and improve patients’ lives,” said Jill Fiedler-Kelly, president of the Cognigen Corporation division of Simulations Plus. With our subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer solutions which bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches.
Classifications
AskAI Classifications
LabelsLinked Companies
